Stryker Corporation
SYK
Rang in Aktien
#190
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Aktienkurs
$304.72
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$116.88B
Veränderung (1 Tag)
1.96%
Veränderung (1 Jahr)
-19.76%
Land
US
Handel Stryker Corporation (SYK)
Kategorie
Healthcare
Umsatz von Stryker Corporation (SYK)
Umsatz im Jun 2026 TTM: $25.84B
Laut den aktuellen Finanzberichten von Stryker Corporation beträgt der derzeitige Umsatz des Unternehmens (TTM) $25.84B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $22.60B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $20.50B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Stryker Corporation von 2000 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $25.84B | 2.87% |
| 2025 | $25.12B | 11.16% |
| 2024 | $22.60B | 10.23% |
| 2023 | $20.50B | 11.11% |
| 2022 | $18.45B | 7.84% |
| 2021 | $17.11B | 19.21% |
| 2020 | $14.35B | -3.58% |
| 2019 | $14.88B | 9.43% |
| 2018 | $13.60B | 9.30% |
| 2017 | $12.44B | 9.88% |
| 2016 | $11.33B | 13.86% |
| 2015 | $9.95B | 2.80% |
| 2014 | $9.68B | 7.25% |
| 2013 | $9.02B | 4.20% |
| 2012 | $8.66B | 4.21% |
| 2011 | $8.31B | 13.48% |
| 2010 | $7.32B | 8.88% |
| 2009 | $6.72B | 0.07% |
| 2008 | $6.72B | 11.96% |
| 2007 | $6.00B | 11.01% |
| 2006 | $5.41B | 10.96% |
| 2005 | $4.87B | 14.29% |
| 2004 | $4.26B | 17.57% |
| 2003 | $3.63B | 20.38% |
| 2002 | $3.01B | 15.73% |
| 2001 | $2.60B | 13.67% |
| 2000 | $2.29B | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $46.59B | 80.30% |
US
|
|
| $35.48B | 37.34% |
IE
|
|
| $21.00B | -18.74% |
US
|
|
| - | - |
DE
|
|
| $6.51B | -74.79% |
US
|
